Cosmetics Europe - The Personal Care Association’s Post

🔊 Interested in the Italian cosmetic market? Our webinar "Access to Global Market" part 2 is taking place tomorrow! It's still time to registrer. Experts will review the Italian cosmetic regulatory landscape. If you've missed the first part, you can catch up here: https://lnkd.in/gqNEPPEq See you tomorrow!

At long last, MoCRA is now here! The new law requires "adequate substantiation of safety" for all cosmetic products and ingredients. This means having scientific evidence that experts would consider sufficient to support a reasonable certainty of product safety. Don't risk non-compliance or selling adulterated products. Partner with Eurofins CRL Cosmetics to ensure your products meet MoCRA's safety standards. We offer comprehensive testing services, including: • Safety In Use studies • Repeat Insult Patch Tests (RIPT) • Stability testing • Preservative Efficacy testing Our state-of-the-art facilities and expert team can provide the scientific data you need to substantiate your products' safety. With over 20,000 completed clinical studies and a database of 35,000 panelists, we have the experience to design customized testing programs that meet your specific needs. Don't wait until it's too late. Contact Eurofins CRL Cosmetics today to schedule your product testing and ensure MoCRA compliance. https://lnkd.in/g7s--CUW #MoCRA #CosmeticSafety #ProductTesting #RegulatoryCompliance #BeautyIndustry #Eurofins

🇦🇺 TGA Australia Guidance 🇦🇺 Are you involved in the cosmetics or therapeutic goods industry in Australia? The TGA has released essential guidance for advertisers and suppliers, aiding in determining product classification. Stay informed on complying with regulatory requirements, including advertising rules. Key Points: - Products are classified based on claims, ingredients, administration method, and exclusions. - This guidance, last updated on June 6, 2024, is crucial but not definitive in product classification. - Regulatory controls involve the AICIS, ACCC, and the Poisons Standard. For a comprehensive understanding of the regulations surrounding cosmetic and therapeutic goods, consult the TGA’s latest guidelines. Stay compliant and informed in this ever-evolving industry landscape. #TGA #Australia #Cosmetics #TherapeuticGoods #RegulatoryCompliance

Our second webinar in June is focusing on Borderline Categorisations. This occurs when cosmetic products overlap with medicines, medical devices, foods, toys and biocides categories, necessitating brands to understand regulatory requirements thoroughly. Dr Theresa Callaghan, with extensive experience in senior R&D roles at companies like LVMH, Unilever, J&J and proDerm for over 35 years, will shed light on the types of borderline cosmetics and how they cross-over with other legislations. Expect many insightful examples and case-by-case analyses. Don't miss this opportunity to broaden your understanding. https://lnkd.in/g7ztMvHH

[Webinar - MoCRA Mastery] Don't forget, next week, Tuesday May 21 at 10am EST, Eurofins Cosmetics & Personal Care invites you to its webinar “MoCRA Mastery: Navigating FDA Changes with Ease”, hosted by Simona Maria Pappalardo, Wagma Amini and Lenore Coyle! The objective: Better understand all the requirements of this new regulation and know the key elements and key deadlines for navigating the complexities of MoCRA compliance. Register now ➡ https://lnkd.in/eUvMjX7A #eurofins #webinar #MoCRA #GlobalExpertisePersonaTouch

Want to register your cosmetics in China..😊 Join us for an insightful webinar🤝🌐 #Webinar #Cosmetics #Regulations #China #Industryinsights

🌟 Exciting News! 🌟   I had the privilege of meeting Nico Shaw Nunez, Director of Regulation, CTPA & attending the conference conducted by CTPA and DBT, where we explored vital topics in the cosmetics industry. Key discussions included:   - Regulatory processes for cosmetics - The necessity of animal testing - Safety and efficacy standards - Classification of cosmetics - Market demands - Intellectual Property (IP) rights and product protection   Additionally, the OMC China office can assist with cosmetic registration and localization in the Chinese market, making it easier for brands to navigate this complex landscape.   It was a fantastic opportunity to network and deepen my understanding of the industry's challenges and innovations. Thank you to all the speakers and organizers for such an informative event! To get more information about medical devices, regulatory affairs, cosmetic industry visit us at omcmedical.com or contact us.   #CosmeticsIndustry #RegulatoryCompliance #AnimalTesting #SafetyAndEfficacy #CosmeticClassification #MarketTrends #IntellectualProperty #ProductProtection #CTPA #DBT #OMC #ChinaMarket #ProfessionalDevelopment

🚨 MoCRA Deadline July 1st: Is Your Cosmetic Brand Ready? 🗓️ Wednesday, June 12, 2024 🕔 5:00 PM - 6:00 PM 🎤 Speaker: Geoff Waby, Board Director - Obelis USA LLC Agenda: ⏳ Is Your Cosmetic Brand Ready for the next MoCRA Deadline on July 1st? 📢 Remember: FDA begins enforcing facility registration and product listing. In the world of beauty, staying ahead is key! All brand owners and manufacturing facilities worldwide selling products in the USA market must be compliant by July 1, 2024. If you're one of these companies, join this webinar to learn what you need to do to meet the FDA MoCRA requirements before the deadline. 🔗 https://lnkd.in/g-VQRfmS #CosmeticCompliance #MoCRA #FDA #BeautyIndustry #RegulatoryAffairs #Compliance #Cosmetics #ObelisGroup #Webinar #CosmeticBrands

Ahead of the adoption of the provisional agreement on the Green Claims Directive by the Council of the EU later this month, Cosmetics Europe together with 11 other industry associations call on Member States to focus on creating a practical and effective regulatory framework. Read our key recommendations ⬇️ https://bit.ly/3KrTNJR

In our new blogpost, we discuss a federal court’s recent ruling that the Montana Attorney General was preempted from de-listing a cigarette manufacturer based on the manufacturer’s alleged violations of the Federal Food, Drug, and Cosmetics Act. See below for analysis and key takeaways from the Troutman Pepper Tobacco Team.